Cite
MLA Citation
Michael S Hofman et al.. “[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study.” Lancet oncology, vol. 19, no. 6, 2018, pp. 825–833. http://access.bl.uk/ark:/81055/vdc_100065599748.0x000018